CHYM Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Chime Financial Inc (CHYM) is not a strong buy for a beginner, long-term investor at this time. While the company shows positive revenue growth and has received significant investment from Forerunner Ventures, the technical indicators are bearish, and the stock is currently underperforming key support levels. Additionally, there are no strong proprietary trading signals or recent congress trading data to support a buy decision. The stock's financials, while improving, still reflect a net income loss, and analyst ratings present mixed opinions with a neutral to slightly positive outlook.
The technical indicators for CHYM are bearish. The MACD is negatively expanding, RSI is neutral at 29.35, and moving averages show a bearish trend (SMA_200 > SMA_20 > SMA_5). The stock is trading below its pivot level of 20.82, with key support at 18.834 and resistance at 22.806.
Forerunner Ventures' significant acquisition of 9,031,107 shares for $227.31 million demonstrates institutional confidence in the company. Revenue increased by 25.49% YoY in Q4 2025, and EPS improved by 140.00% YoY.
The company reported a net income loss of $1.01 billion in the trailing twelve months. Technical indicators are bearish, and the stock has a 60% chance of declining 3.54% in the next week. Analysts have lowered price targets, citing credit risk and exposure as potential long-term challenges.
In Q4 2025, revenue increased to $596.36 million, up 25.49% YoY. Net income improved significantly but remains negative at -$44.78 million. EPS increased to -0.12, up 140.00% YoY. Gross margin improved slightly to 88.2%.
Analyst ratings are mixed. KeyBanc initiated coverage with an Overweight rating and a $30 price target, citing Chime's strong tech stack and growth potential. However, firms like Evercore ISI and Morgan Stanley have lowered price targets, citing broader market derating and credit risk concerns. UBS maintains a Neutral rating with a $27 price target.
